Literature DB >> 9095501

Specificity of monoclonal antibodies against ABH and related structures tested by ELISA with synthetic glycoconjugates.

R Rieben1, E Y Korchagina, N V Bovin, M R Daha.   

Abstract

We have tested 88 monoclonal antibodies with proposed specificities against ABH- and related antigens in an ELISA with synthetic oligosaccharide conjugates as coating substances. All mabs were tested for binding towards A-, B-, and H type I trisaccharides, the B disaccharide, and the proposed anti-A and -AB were also tested on A tetrasaccharide type I. Of the 50 mabs with proposed A- and/or B-specificity, 28 showed a specific reaction in our ELISA. Cross-reactivity with other ABH-antigens was observed for 7 of these 50 anti-A/B mabs and 15 of them did not react in the ELISA. Only 2 of the 17 mabs submitted as anti-H bound to H trisaccharide type I, one of them showed a polyspecific reactivity pattern, and the remaining 14 did not react with our type I antigen. Of the mabs with other than ABH-specificities only one, supposedly anti-P1, showed cross-reactivity with one of our coating antigens, in this case the B trisaccharide.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9095501     DOI: 10.1016/s1246-7820(97)80010-9

Source DB:  PubMed          Journal:  Transfus Clin Biol        ISSN: 1246-7820            Impact factor:   1.406


  3 in total

1.  Synthetic blood group antigens for anti-A removal device and their interaction with monoclonal anti-A IgM.

Authors:  Jennifer C Solovan; Heung-Il Oh; Azadeh Alikhani; Shalini Gautam; Katherine Vlasova; Elena Y Korchagina; Nicolai V Bovin; William J Federspiel
Journal:  Transpl Immunol       Date:  2006-09-01       Impact factor: 1.708

2.  Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease.

Authors:  H E Baxendale; M Johnson; R C M Stephens; J Yuste; N Klein; J S Brown; D Goldblatt
Journal:  Clin Exp Immunol       Date:  2007-11-05       Impact factor: 4.330

3.  High molecular weight blood group A trisaccharide-polyacrylamide glycoconjugates as synthetic blood group A antigens for anti-A antibody removal devices.

Authors:  Azadeh Alikhani; Elena Y Korchagina; Alexander A Chinarev; Nicolai V Bovin; William J Federspiel
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2009-11       Impact factor: 3.368

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.